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HEPES-Hanks buffer (pH 7.4) was then added to each
suspension. Each suspension was then left to settle for 20
min at 4°C. The top 45 ml of each suspension was withdrawn
and passed through cheesecloth to remove solid debris. The
suspensions were then centrifuged for 10 min (5,000 x g),
and the pellets were resuspended in 5 ml of HEPES-Hanks
buffer (pH 7.4). CFU per ml in each suspension was determined by plating on selective medium. Fimbriae were
sheared from the bacteria in each suspension by blending
five times for 1 min with 1-min intervals on ice. Bacteria
were then pelleted by centrifugation for 10 min at 7,710 x g,
leaving fimbriae in the supernatant. Urea was added to a final
concentration of 1 M, and each supernatant was then overlaid on a 1 M urea-5 mM Tris-1 M sucrose cushion buffer
and subjected to ultracentrifugation (150,000 x g, overnight)
as described previously (6). The pellets were resuspended in
water and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, as described by Laemmli (7).
Proteins separated on the gel were transferred to nitrocellulose and analyzed by Western blotting (immunoblotting) as
described by Krogfelt and Klemm (6). Free binding sites on
the nitrocellulose were blocked with 2% Tween 20, and the
nitrocellulose was incubated with specific anti-type 1 antiserum. Binding of anti-type 1 antibodies to the fimbrial
proteins was visualized by subsequent incubation with peroxidase-labeled goat anti-rabbit immunoglobulin G and tetramethylbenzidine. The anti-type 1 antibodies utilized were
raised in rabbits against purified type 1 fimbriae by Krogfelt
and Klemm (6). Prior to utilization, the antiserum was
adsorbed with whole E. coli F-18 FimA- in order to remove
nonspecifically reactive antibodies.
Type 1 fimbrial subunits were observed in the cecal mucus
of mice colonized by E. coli F-18 but not in mice colonized
by E. coli F-18 FimA- (Fig. 1, lanes 3 and 4). Interestingly,
E. coli F-18 appeared to overexpress type 1 fimbriae in
mouse cecal mucus in vivo relative to the amount expressed
in vitro in L broth (Fig. 1, lanes 2 and 3). That is, judging
from the immunoblot signal, 107 CFU of E. coli F-18
obtained from cecal mucus in vivo appeared to produce
significantly more type 1 fimbrial subunits than 107 CFU of
E. coli F-18 grown standing in L broth at 37°C for 48 h and
added to cecal mucus. Also, during the type 1 fimbriae
purification procedure, 17-kDa (monomer) and 34-kDa (dimer) fimbrial subunits were copurified, yet for reasons which

Mannose-sensitive binding of Escherichia coli bearing
type 1 fimbriae to intestinal epithelial cells has long been
recognized (4, 5); however, the role of type 1 fimbriae in
intestinal colonization has been controversial. Studies of
neonatal diarrhea in pigs have shown the infectivity of
enterotoxigenic E. coli with the type 1 fimbriated phenotype
to be several times higher than that of the nonfimbriated
counterpart (9), yet other studies have shown that type 1
fimbriae are not produced by enterotoxigenic E. coli in the
pig small intestine during disease (10). In addition, it has
been recently reported that the loss of type 1 fimbriae in a
systemically invasive E. coli Ki strain did not alter its ability
to colonize the large intestines of neonatal rats but did result
in a drastic decrease in oropharyngeal colonization (1).
E. coli F-18, which was isolated from the feces of a healthy
human, is an excellent colonizer of the streptomycin-treated
mouse large intestine (2, 3). E. coli F-18 harbors the fim
operon and makes type 1 fimbriae (8). Furthermore, adhesion of E. coli F-18 to specific glycoprotein receptors present
in cecal and colonic mucus and to cecal and colonic brush
border membranes can be inhibited by D-mannose (12),
suggesting that E. coli F-18 type 1 fimbriae may mediate
adhesion to intestinal mucosal components.
Recently, we reported that E. coli F-18 and E. coli F-18
FimA- (an isogenic strain which is unable to make type 1
fimbriae) could, when fed to mice simultaneously, colonize
the streptomycin-treated mouse large intestine equally well,
each strain persisting at approximately 107 CFU per g of
feces (8). These data provided clear evidence that the ability
to synthesize type 1 fimbriae was not a prerequisite for large
intestine colonization and suggested the possibility that E.
coli F-18 did not produce type 1 fimbriae in the large
intestine in vivo.
To test this hypothesis, cecal mucus was collected from
six streptomycin-treated mice colonized for 10 days with E.
coli F-18 and from six streptomycin-treated mice colonized
for 10 days with E. coli F-18 FimA-. Each sample was
placed in 5 ml of N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES)-Hanks buffer (pH 7.4), as described
previously (11). Each of the two samples was homogenized
in a Dounce homogenizer for 2 min. Forty-five milliliters of
*
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Escherichia coli F-18, isolated from the feces of a healthy human, makes type fimbriae and is an excellent
colonizer of the streptomycin-treated mouse large intestine. Recently, it was shown that the inability to produce
type 1 fimbriae had no effect on the ability of E. coli F-18 to colonize the streptomycin-treated mouse large
intestine, suggesting the possibility that E. coli F-18 does not express type 1 fimbriae in vivo. However, we show
here that E. coli F-18 does express type 1 fimbriae in mouse cecal mucus in vivo and, in fact, appears to express
substantially more type 1 fimbriae in cecal mucus in vivo than in L broth in vitro.
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